Lobbying

Sickle Cell Disease Association of America's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q3 2023; the issues it reports most are Health Issues and Medicare/Medicaid.

Sickle Cell Disease Association of America

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$60K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q3 2023
The first quarter a report named it

Lobbying by quarter

Sickle Cell Disease Association of America lobbying by quarter
Sickle Cell Disease Association of America lobbying by quarter
QuarterAmountReports
Q3 2023$20K1
Q4 2023$20K1
Q1 2024$20K1
Q2 2024$20K1
Q3 2024$20K1
Q4 2024$20K1
Q1 2025$20K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$20K1
Q1 2026$20K1
Q2 2026$20K1
Q3 2026$00

By issue

  • Health issues$69K · 12 reports
  • Medicare and Medicaid$69K · 12 reports
  • Budget and appropriations$52.3K · 10 reports
  • Insurance$25K · 5 reports
  • Pharmacy$15.7K · 3 reports
  • Medical research and clinical labs$9,000 · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)12 reports
  • Health & Human Services, Dept of (HHS)12 reports
  • HOUSE OF REPRESENTATIVES12 reports
  • SENATE12 reports
  • Social Security Administration (SSA)7 reports
  • Food & Drug Administration (FDA)3 reports
  • Centers For Disease Control & Prevention (CDC)2 reports

Firms it paid

Firm
Artemis Policy Group$240K12 quarters

Former officials lobbying for it

Former position
LESLIE BRADYHealth Policy Advisor/Legislative Assistant, Rep. Brian HigginsQ2 2026

Lobbying reports

Filed by
07/20for Q2Artemis Policy Group$20K
04/20for Q1Artemis Policy Group$20K
01/20for Q4 2025Artemis Policy Group$20K
25/10/20for Q3 2025Artemis Policy Group$20K
25/07/18for Q2 2025Artemis Policy Group$20K
25/04/21for Q1 2025Artemis Policy Group$20K
25/01/20for Q4 2024Artemis Policy Group$20K
24/10/18for Q3 2024Artemis Policy Group$20K
24/07/22for Q2 2024Artemis Policy Group$20K
24/04/22for Q1 2024Artemis Policy Group$20K
24/01/22for Q4 2023Artemis Policy Group$20K
23/10/20for Q3 2023Artemis Policy Group$20K
23/07/26for Q3 2023Artemis Policy GroupUnder $5,000